TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.87% | 2.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.87% | 2.44% | |||
| Cost of Revenue | 5.95% | 10.47% | |||
| Gross Profit | -1.52% | -0.96% | |||
| SG&A Expenses | -4.70% | -8.62% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.57% | -3.54% | |||
| Operating Income | 11.99% | 16.82% | |||
| Income Before Tax | -3.41% | 13.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.09% | 13.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.09% | 13.30% | |||
| EBIT | 11.99% | 16.82% | |||
| EBITDA | 12.09% | 17.08% | |||
| EPS Basic | 7.66% | 13.40% | |||
| Normalized Basic EPS | 18.24% | 13.13% | |||
| EPS Diluted | 7.66% | 13.40% | |||
| Normalized Diluted EPS | 18.24% | 13.13% | |||
| Average Basic Shares Outstanding | 13.79% | 0.12% | |||
| Average Diluted Shares Outstanding | 13.79% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||